Zentalis Pharmaceuticals, Inc.
$334.64M- Market cap
- $285.97M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 4.96x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · current priceP/S 4.24x
$3.99Latest market snapshot
Implied fair value · at AVGO's multiple
$25.07528.4% above market
0.94 ZNTL revenue / share×26.65x AVGO P/S=$25.07
Market $3.99Implied $25.07
AVGO · current priceP/S 26.65x
$357.90Latest market snapshot
Implied fair value · at ZNTL's multiple
$56.9584.1% below market
13.43 AVGO revenue / share×4.24x ZNTL P/S=$56.95
Market $357.90Implied $56.95
